-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AAeGwbnMW8k3GKNTMOBa/yRByvAPVpVYRIAtBFU+o8RgpvjH7H536ST/Ya09ko5L AuGF92zgrBdZTcFsk+Np7Q== 0000898430-07-003031.txt : 20070816 0000898430-07-003031.hdr.sgml : 20070816 20070816193613 ACCESSION NUMBER: 0000898430-07-003031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070814 FILED AS OF DATE: 20070816 DATE AS OF CHANGE: 20070816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PONIARD PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000755806 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 911261311 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 BUSINESS PHONE: 2062817001 MAIL ADDRESS: STREET 1: 300 ELLIOTT AVENUE WEST STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98119-4114 FORMER COMPANY: FORMER CONFORMED NAME: NEORX CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDFISCHER CARL CENTRAL INDEX KEY: 0001110780 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-16614 FILM NUMBER: 071063650 BUSINESS ADDRESS: STREET 1: 161 WEST 61 STREET CITY: NEW YORK STATE: NY ZIP: 10023 BUSINESS PHONE: 2125818170 MAIL ADDRESS: STREET 1: 161 WEST 61ST STREET CITY: NEW YORK STATE: NY ZIP: 10022 4 1 rrd169852.xml AUGUST PURCHASE #2 X0202 4 2007-08-14 0 0000755806 PONIARD PHARMACEUTICALS, INC. PARD 0001110780 GOLDFISCHER CARL BAY CITY CAPITAL LLC 750 BATTERY STREET SAN FRANCISCO CA 94111 1 0 0 0 Common Stock 2007-08-14 4 P 0 28 5.50 A 270636 I See footnote Common Stock 2007-08-14 4 P 0 1 5.50 A 4665 I See footnote Common Stock 2007-08-16 4 P 0 223 5.4838 A 270859 I See footnote Common Stock 2007-08-16 4 P 0 4 5.4838 A 4669 I See footnote Represents the indirect interest of Dr. Goldfischer in (i) 458 shares of Common Stock purchased by Bay City Capital Fund IV, L.P. ("Fund IV") on August 14, 2007, resulting in 4,391,734 shares of Common Stock held by Fund IV after such purchase and (ii) 3,622 shares of Common Stock purchased by Fund IV on August 16, 2007, resulting in 4,395,356 shares of Common Stock held by Fund IV after such purchase. Dr. Goldfischer is a limited partner in Fund IV and a member of Bay City Capital Management IV, LLC ("Management IV"), the general partner of Fund IV. Dr. Goldfischer is also a member and manager of Bay City Capital LLC ("BCC"), a member and the manager of Management IV. Dr. Goldfischer disclaims any beneficial ownership in any of such shares. Represents the indirect interest of Dr. Goldfischer in (i) 10 shares of Common Stock purchased by Bay City Capital Fund IV Co-Investment Fund, L.P. ("Co-Investment IV") on August 14, 2007, resulting in 94,663 shares of Common Stock held by Co-Investment IV after such purchase and (ii) 78 shares of Common Stock purchased by Co-Investment IV on August 16, 2007, resulting in 94,741 shares of Common Stock held by Co-Investment IV after such purchase. Dr. Goldfischer is a member of Management IV, the general partner of Co-Investment IV. Dr. Goldfischer is also a member and manager of BCC, a member and the manager of Management IV. Dr. Goldfischer disclaims any beneficial ownership in any of such shares. /s/ Carl Goldfischer 2007-08-16 -----END PRIVACY-ENHANCED MESSAGE-----